Insmed Incorporated
INSM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $30 | $19 | $14 | $12 |
| - Cash | $0 | $1 | $0 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $31 | $19 | $15 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 32.5% | 15.7% | -11.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.7% | 73.9% | 77.1% | 75% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -241.9% | -276.6% | -250.8% | -202.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -260% | -299.5% | -276.4% | -225.5% |
| EPS Diluted | -1.75 | -1.7 | -1.42 | -1.32 |
| % Growth | -2.9% | -19.7% | -7.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |